| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |